The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Krivulka Joseph J since year 2005.
The trader's CIK number is 1296750.
At the time of this reporting, Krivulka Joseph J is the Director of Nektar Therapeutics .
(stock ticker symbol NKTR).
See this page for all insider trading activities at Nektar Therapeutics .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2017-06-26||NKTR||Nektar Therapeutics||Option Ex||15,000||8.37||125,549|
|2016-09-15||NKTR||Nektar Therapeutics||Option Ex||15,000||.00||0|
|2015-07-24||NKTR||Nektar Therapeutics||Option Ex||15,000||8.81||132,150|
|2013-02-19||AOLS||Aeolus Pharmaceuticals, Inc.||Buy||400,000||.00||0|
|2012-04-05||AOLS||Aeolus Pharmaceuticals, Inc.||Buy||333,333||.30||99,999|
|2011-03-07||NKTR||Nektar Therapeutics||Option Ex||10,000||.00||0|
|2008-11-14||NKTR||Nektar Therapeutics||Option Ex||5,000||.00||0|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Krivulka Joseph J (Director of Nektar Therapeutics at the time of this reporting) see the Securities and Exchange Commission (SEC) website.